Related Experiment Videos
Intraoperative magnetic resonance imaging during transsphenoidal surgery
R Fahlbusch1, O Ganslandt, M Buchfelder
1Department of Neurosurgery, University Erlangen-Nürnberg, Erlangen, Germany.
Journal of Neurosurgery
|September 22, 2001
Summary
Intraoperative magnetic resonance (MR) imaging enhances transsphenoidal microsurgery for pituitary macroadenomas. This allows for early assessment of tumor removal, improving complete resection rates and enabling timely planning of further treatments.
Area of Science:
- Neurosurgery
- Radiology
- Oncology
Background:
- Transsphenoidal microsurgery is a common approach for pituitary macroadenomas.
- Assessing complete tumor resection traditionally requires postoperative imaging weeks later.
- Non-hormone-secreting pituitary macroadenomas present unique challenges in surgical resection assessment.
Purpose of the Study:
- To evaluate the efficacy of intraoperative magnetic resonance (MR) imaging in transsphenoidal microsurgery.
- To determine if intraoperative MR imaging improves the assessment of tumor resection for pituitary macroadenomas.
- To assess the impact on complete tumor removal rates and subsequent treatment planning.
Main Methods:
- Utilized a 0.2-tesla intraoperative MR imager in a specialized operating room.
- Performed microsurgery with MR-compatible instruments and acquired coronal/sagittal T1-weighted images.
- Compared intraoperative findings with postoperative 1.5-tesla MR images obtained 2-3 months post-surgery.
Main Results:
- Intraoperative MR imaging enabled ultra-early evaluation of tumor resection in 73% of 44 patients with large pituitary macroadenomas.
- A second intraoperative examination in 24 patients led to additional resection in 15 (34%) for suspected tumor remnants.
- Confirmed reliability of intraoperative assessment compared to conventional postoperative imaging.
Conclusions:
- Intraoperative MR imaging provides a crucial "second look" during surgery for incomplete tumor resection.
- This capability significantly improves the rate of complete tumor removal in pituitary macroadenoma surgeries.
- Facilitates early planning of additional treatments for patients with residual tumor, optimizing patient management.